Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Partnership Creates Prototype Tool for Nanoparticles; Combi Shares Close Up 10.4 Percent on News

NEW YORK, Dec. 15 (GenomeWeb News) - CombiMatrix and partner Nanomaterials Discovery Corporation have created a prototype workstation for the combinatorial discovery and development of new nanomaterials, the firms said today.

The news, which is considered a milestone by the partners, caused shares in CombiMatrix yesterday to close up 10.35 percent at $4.05 in unusually heavy volume.

 

CombiMatrix and NDC penned an alliance to discover and develop new nanomaterials, nanotechnology tools, and associated intellectual property. Terms of the deal called for CombiMatrix to license its semiconductor microarray technology exclusively to NDC. NDC would use the technology in its combinatorial nanomaterials-discovery efforts for applications that include fuel cell catalysts, materials for rechargeable batteries, and electro-optic materials for telecommunications and displays.

NDC is complementing its nanomaterials discovery programs by developing a workstation for high-throughput nanomaterials screening using CombiMatrix's nanoarray hardware. "These workstations enable more efficient nanomaterials discovery efforts by capturing the intrinsic value of CombiMatrix's highly parallel nanoarray technology," NDC said.

 

CombiMatrix and NDC will share revenue from any commercially viable new nanomaterials that are discovered, as well as the sale of the workstations, the companies said.

 

Details of the technology, such as its targeted customer base, were not disclosed.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.